The importance of the management of infectious complications for patients with left ventricular assist device

Michinari Hieda, Makoto Sata, Takeshi Nakatani

Research output: Contribution to journalReview articlepeer-review

9 Citations (Scopus)

Abstract

A left ventricular assist device (LVAD) therapy is the viable option for patients with advanced heart failure as a bridge to transplantation, bridge to recovery, or destination therapy. Although application of LVAD support has become a standard option, serious complications or adverse events related with LVAD remain a concern. LVAD-related infection including driveline infection (DLI) and bloodstream infection (BSI) is one of the serious clinical matters for LVAD patients, and especially BSI leads to the high incidence of mortality. The LVAD-related infections negatively impact patient’s quality of life. Therefore, control of infection is one of the primary goals of management in LVAD patients. Several efforts including early and appropriate intervention including antibiotics and wound care may contribute to avert the progress into BSI from localized DLI. Particularly, there are clinical secrets in how to use antibiotics and how to treat wound care in LVAD patients. The rational way of thinking for wound care will be introduced in this review.

Original languageEnglish
Pages (from-to)750-756
Number of pages7
JournalHealthcare (Switzerland)
Volume3
Issue number3
DOIs
Publication statusPublished - Sep 2015
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Health Informatics
  • Health Policy
  • Health Information Management
  • Leadership and Management

Fingerprint

Dive into the research topics of 'The importance of the management of infectious complications for patients with left ventricular assist device'. Together they form a unique fingerprint.

Cite this